🔗 Share this article

Grammy-winning R&B singer D’Angelo passed away on October 14 at 51 years old after a private battle with pancreatic cancer.

“The brilliant light of our family has dimmed his light for us in this life,” his family confirmed. “After a lengthy and brave battle with the disease, we are heartbroken to declare that D’Angelo, known to his followers around the globe as D’Angelo, has been taken from us.”

D’Angelo made a lasting impact on music with his pioneering neo-soul sound and partnerships with high-profile artists.

He launched his debut album, “Brown Sugar,” in the mid-nineties to immediate acclaim. The record reached the fourth spot on Billboard’s Top R&B Albums chart, went platinum later that year, and earned multiple Grammy nominations.

However, it was his sophomore release, “Voodoo,” in 2000 that boosted his music career into the stratosphere. The record debuted at the top spot on both the R&B charts and the Billboard 200. He received two Grammys: Best R&B Album and Best Male R&B Vocal Performance for “Untitled (How Does It Feel).”

The visual for “Untitled (How Does It Feel)” solidified D’Angelo’s reputation as a icon, albeit a reluctant one, in the public consciousness. The personal depiction showed the artist, notably stripped down to his waist, performing straight into the lens.

D’Angelo retreated from the spotlight after putting out Voodoo and publicly struggled with drugs and alcohol. In 2005, he was involved in a serious car crash that put him in grave health.

Over ten years later, his third and final album, “Black Messiah” (2014), reaffirmed his enduring appeal with a further No. 1 debut on the R&B chart and a Grammy for Top R&B Record.

Once more, in his own mysterious way, D’Angelo had limited public appearances in the subsequent period.

The singer was scheduled as a top act for the 2025 Roots Picnic festival, but his performance was called off, citing an “unforeseen medical delay.”

Although information is limited about D’Angelo’s well-being in the months leading up to his death, he had reportedly been hospitalized for months and in palliative care for two weeks.

D’Angelo’s demise is a clear example of the devastating effects of pancreatic malignancy, one of the most deadly and least preventable forms of the disease, on a brilliant talent whose existence was ended too soon.

“We are grieved that he can only provide cherished moments with his family, but we are eternally grateful for the heritage of deeply emotional songs he has left us,” his kin said.

Pancreatic Cancer: Lethal and Difficult to Avoid

Pancreatic malignancy impacts the digestive organ, a small organ that produces insulin and plays an essential role in breaking down food, among other functions. The size and location of the organ in the human system make it more challenging to detect cancer.

Even though this cancer accounts for only about 3% of malignancy cases annually in the U.S., it is responsible for 7% of cancer deaths.

Nearly 70,000 people will be found to have pancreatic cancer and about 52,000 will die of the disease in the year 2025.

“Pancreatic cancer is one of the deadliest cancers, with an aggressive tumor and poor prognosis. We have few and poor therapies, and a narrow opportunity to make a meaningful impact on the lives of people,” said a cancer specialist.

Since pancreatic cancer rarely causes initial signs, it’s often diagnosed only once the disease is late-stage. Even when a individual has symptoms they are usually vague and may be confused with a number of everyday ailments.

“As of yet, there is no good way to detect this malignancy in the early stages, apart from paying attention to physical changes and speaking with your physician if there are unfamiliar signs,” explained a health expert.

Common symptoms of this disease encompass:

• abdominal or lower back pain
• weight loss
• yellowing of skin and eyes
• reduced hunger
• dark urine
• pale or fatty bowel movements
• diarrhea
• increased appetite or thirst
• feeling sick

At 51 years old, D’Angelo’s death is an outlier, as pancreatic cancer is typically found in adults in the 65 to 75 range. However, numerous malignancies, such as this type, have become more common among younger adults.

“Pancreatic cancer identified before the age of 50 is deemed rare, yet concerningly, clinicians are beginning to see a rising count of younger patients suffering from this condition,” said a specialist.

Family History Impacts Disease Probability

Without effective detection methods for pancreatic cancer, professionals emphasized the significance of understanding your relatives’ health background. Certain contributing elements, such as smoking and obesity also have an influence in the onset of pancreatic cancer.

African Americans have the greatest occurrence of this malignancy in the U.S. and are more prone to be diagnosed with untreatable disease.

“The initial action toward lowering one’s chance of this condition is assessing personal risk factors. People should examine their genetic background, genetic background, and medical conditions, such as blood sugar disease, long-term pancreas inflammation, or obesity that may raise their susceptibility,” advised a medical professional.

Inherited genetic elements are linked to as much as 10% of all this malignancy instances. If someone in your family has had pancreatic cancer, you may want to consider genetic testing.

“For people with a family history of this condition or those carrying elevated risk DNA changes, screening may involve sophisticated scans such as MRI scans or internal ultrasound to find early changes in the organ,” he explained.

For those wishing to lower their chance, habit adjustments may make a difference. The most effective step you can take to lower your risk of this disease is to quit smoking, and if you don’t smoke, avoid exposure altogether.

Heavy drinking is associated with pancreas inflammation, a contributing element for pancreatic cancer, so limiting or avoiding alcohol may help reduce your risk.

Managing your weight or shedding pounds may also help decrease your susceptibility. Individuals with obesity are twenty percent more prone to develop this disease. This malignancy also is more frequent in those with blood sugar issues, and reducing weight can also lower the chance of type 2 diabetes.

Despite this disease’s poor prognosis, there is reason for optimism.

“We are making progress with treatments and more recent combination chemotherapy. There are developing targeted therapies that already are showing results,” remarked a expert.

For many people, however, awareness about this uncommon but {dev